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Abstract
Background: Rhodopsin, the prototypic member of G protein-coupled receptors (GPCRs), undergoes isomerization of 11-
cis-retinal to all-trans-retinal upon photoactivation. Although the basic mechanism by which rhodopsin is activated is well
understood, the roles of whole transmembrane (TM) helix-III during rhodopsin photoactivation in detail are not completely
clear.
Principal Findings: We herein use single-cysteine mutagenesis technique to investigate conformational changes in TM
helices of rhodopsin upon photoactivation. Specifically, we study changes in accessibility and reactivity of cysteine residues
introduced into the TM helix-III of rhodopsin. Twenty-eight single-cysteine mutants of rhodopsin (P107C-R135C) were
prepared after substitution of all natural cysteine residues (C140/C167/C185/C222/C264/C316) by alanine. The cysteine
mutants were expressed in COS-1 cells and rhodopsin was purified after regeneration with 11-cis-retinal. Cysteine
accessibility in these mutants was monitored by reaction with 4, 49-dithiodipyridine (4-PDS) in the dark and after
illumination. Most of the mutants except for T108C, G109C, E113C, I133C, and R135C showed no reaction in the dark. Wide
variation in reactivity was observed among cysteines at different positions in the sequence 108–135 after photoactivation.
In particular, cysteines at position 115, 119, 121, 129, 131, 132, and 135, facing 11-cis-retinal, reacted with 4-PDS faster than
neighboring amino acids. The different reaction rates of mutants with 4-PDS after photoactivation suggest that the amino
acids in different positions in helix-III are exposed to aqueous environment to varying degrees.
Significance: Accessibility data indicate that an aqueous/hydrophobic boundary in helix-III is near G109 and I133. The lack
of reactivity in the dark and the accessibility of cysteine after photoactivation indicate an increase of water/4-PDS
accessibility for certain cysteine-mutants at Helix-III during formation of Meta II. We conclude that photoactivation resulted
in water-accessible at the chromophore-facing residues of Helix-III.
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Introduction
G-protein-coupled receptors (GPCRs), the largest known family
of cell surface receptors, mediate a wide variety of signal
transduction processes. Upon recognition of diverse extracellular
signals including hormones, neurotransmitters, olfactants, tastants,
and light, GPCRs initiate intracellular signaling by interacting
with heterotrimeric G proteins [1]. Rhodopsin defines the
rhodopsin-like (class A) family within the large GPCR superfamily
[1] and it is the earliest GPCR for which a high-resolution crystal
structure has been determined [2]. Rhodopsin consists of
cytoplasmic (CP), transmembrane (TM), and extracellular (EC)
domains. The mechanism by which rhodopsin is activated has
been extensively characterized [2–14]; the most relevant studies in
this regard include the recently determined crystal structure of
inactive [2] and partially activate rhodopsin [7,8]; site-directed
spin labeling and double electron-electron resonance (DEER)
studies [9]; the model of two protonation switches operating at the
Schiff base (E113) and the cytosol (E134) [10,11]; and the function
of structural waters [12–14].However, the role of TM helix-III in
rhodopsin photoactivation remains unclear.
Rhodopsin is composed of the 40-kDa apoprotein opsin (348 amino
acids) and its chromophore 11-cis-retinal, which acts as an inverse
agonist in the rhodopsin ground state [15]. It is well known that light
induces rhodopsin isomerization from 11-cis-retinal to all-trans-
retinal. This isomerization activates the receptor by causing
movements of the TM helices, which, in turn, induce conformational
changes in the CP domain that result intransitionto the activated state
[16]. This state is competent for binding the heterotrimeric G-protein
of the rod cell transducin (Gt), and for catalysis of the uptake of
guanosine triphosphate by the a-subunit of Gt, thereby initiating the
enzymaticcascade thatleadsto light detection and ultimately to vision.
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e17398Several approaches, including electron paramagnetic reso-
nance, nuclear magnetic resonance, and crystallization, have been
used to obtain insight into the structure of rhodopsin and its
conformational changes on light activation [2–19]. Site-directed
cysteine mutagenesis followed by biochemical and biophysical
analysis of rhodopsin has also extensively been employed for
determining secondary and tertiary structure of CP in rhodopsin
[20–23]. A particular sulfhydryl specific reagent, 4, 49-dithiodipyr-
idine (4-PDS), can be used as a probe to determine the cysteine
reactivity in rhodopsin mutants. Rhodopsin carrying a free
sulfhydryl group reacts with 4-PDS to form the dipyridinyl
derivative. The rate of this reaction is very sensitive to the
accessibility of the cysteine [16].
The aim of this study is to better understand GPCR activation
by investigating the conformational changes of rhodopsin upon
light activation. Cysteines introduced one at a time along the full
length of the TM helices will be tested for their accessibility and
consequent reactivity to sulfhydryl reagents in the dark and on
light activation.
To determine the conformational changes of rhodopsin on light
activation, a basal rhodopsin mutant was constructed replacing the
six naturally-occurring free cysteine residues with the neutral
amino acid alanine, to avoid ambiguity caused by signals derived
from natural cysteines in rhodopsin. As shown in Figure 1, twenty-
eight single-cysteine substituted mutants of helix-III (P107-R135)
were generated based on the basal rhodopsin mutant (C140A/
C167A/C185A/C222A/C264A/C316A). Single-cysteine substi-
tuted mutants on the background of the basal mutant were
analyzed by rhodopsin chromophore formation, bleaching behav-
ior, and Meta II decay. In addition, the accessibility of cysteine in
each of these mutants was monitored by reaction of sulfhydryl
group with 4-PDS in the dark and after illumination for
30 seconds. The results suggest that there is an aqueous/
hydrophobic boundary in helix-III near G109 and I133. The
chromophore-facing residues of Helix-III become water-accessible
after photoactivation.
Materials and Methods
Materials
All-trans-retinal, 4-PDS and phenylmethylsulfonylfluoride (PMSF)
were purchased from Sigma (St. Louis, MO). n-dodecyl-b-D-
maltopyranoside (DM)was acquired from Anatrace (Maumee, OH).
Antirhodopsin monoclonal antibody rho-1D4 was purified from
myeloma cell lines and coupled to cyanogen bromide-activated
Sepharose 4B (Sigma) as described elsewhere [24]. The nonapeptide
corresponding to the C-terminal sequence of rhodopsin, which was
used to elute rhodopsin samples from the antibody 1D-4 sepharose
matrix, was prepared at the MIT Biopolymers Laboratory. The
buffers used were the following: buffer A, PBS buffer: 137 mM
NaCl, 2.7 mM KCl, 1.8 mM KH2PO4,1 0 m MN a 2HPO4
(pH 7.2); buffer B, buffer A plus 1% DM (w/vol); buffer C, buffer
A plus 0.05% DM; buffer D, 2 mM NaPi (pH 6.0), 0.05% DM;
bufferE,2 mMNaPi(pH6.0),0.05%DM,100 mMnonpeptide;and
buffer F, 2 mM NaPi (pH8.0), 0.05% DM.
Construction of single-cysteine mutants P107C-R135C in
vector PMT4
A synthetic opsin construct containing the mutations C140A,
C167A, C185A, C222A, C264A, and C316A was generated
(‘‘basal mutant’’). All of the single-cysteine mutants in the sequence
107–135 were derivatives of this mutant, which are labeled as
P107C–R135C/Basal mutant. As controls for the experiments,
similar single-cysteine substituted mutants at amino acid positions
107–135 were generated on the background of wild type (WT)
rhodopsin, containing the six natural cystein residues, which are
labeled as P107C–R135C/WT.
The mutants P107C, T108C, G109C, and N111C were
prepared by fragment replacement mutagenesis in the synthetic
gene for bovine opsin [25] and cloned in the expression vector
PMT4 [26]. The restriction fragments NcoI/XhoI (nucleotides
302–339) containing the single-cysteine substitutions of these
constructs were used to replace the NcoI/XhoI fragment of the
basic mutant. For mutants G114C, F115C, F116C, A117C,
T118C, L119C, G120C, G121C, E122C, I123C, A124C, L125C,
W126C, S127C, L128C, and V129C, DNA duplexes containing
the cysteine codons (TGC) replaced the native restriction fragment
XhoI/PvuI (nucleotides 339–403). For mutants V130C, L131C,
A132C, I133C, E134C, and R135C, DNA duplexes containing
the cysteine codons replaced the native restriction fragment speI/
BsaAI (nucleotides 387–413).
PCR mutagenesis was used for preparation of the mutants
L112C/Basal mutant and E113C/Basal mutant. The first step
involved PCR reactions with the A132C/Basal plasmid as the
template, using the following primers containing the above single-
cysteine codon, one at a time: the primer 59 CTG CAA GAA
TTC ATG AAC GGT ACC GAA GGC CCA (EcoRI); the
primer 59 GAC TAC TAG TGA CCA CAG TGC AAT TTC
ACC GCC CAG GGT GGC AAA GAA GCC CTC GCA GTT
for L112C; and the primer 59 GAC TAC TAG TGA CCA CAG
TGC AAT TTC ACC GCC CAG GGT GGC AAA GAA GCC
GCA GAG GTT (speI) for E113C (the cysteine-coding codon is in
italics). The PCR products were digested to provide the EcoRI/
speI fragments (nucleotides 2–387) containing the cysteine codons,
which were then subcloned into the large fragment speI/EcoRI
(nucleotides 388–6182) of the L119C/Basal mutant. The DNA
sequences of the fragments containing the mutated regions in all
constructs were confirmed by the dideoxynucleotide sequencing
method.
Expression and purification of rhodopsin
Transient transfection of COS-1 cells and treatment of the
harvested cells with 11-cis-retinal were performed as previously
described [24]. In brief, for expression of opsin in COS-1 cells,
15 mg of plasmid DNA was used to transfect a plate (150625 cm)
of confluent COS-1 cells and the cells were harvested 50–
Figure 1. A secondary structure model of rhodopsin. Naturally
occurring cysteines (dotted circles) and amino acid residues (P107-R135)
mutated in this study are highlighted.
doi:10.1371/journal.pone.0017398.g001
Roles of TM Helix-III in Rhodopsin Photoactivation
PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e1739856 hours post-transfection and washed two times with buffer A.
The cell pellets were stored at 278uC. For rhodopsin purifica-
tion, the cell pellets were warmed up to 20uCa n dr e s u s p e n d e di n
buffer A containing 11-cis-retinal (final concentration: 25 mM)
and 0.1 mM PMSF (2 mL/plate) at 4uCw i t he n d - o v e r - e n d
mixing for 4 h in the dark for generating the rhodopsin
chromophore. Then the pellet cells were placed in the
SORVALL RC-5 (8000 rpm, 4uC, 10 min) and solubilized in
buffer B containing 1% DM and 0.1 mM PMSF for 1 h at 4uC.
The suspension was centrifuged at 35,000 rpm for 30 min at 4uC
in a Ti60 rotor to remove the insoluble material. Mutant
rhodopsins were purified by using 1D4-sepharose 4B affinity
chromatography as previously described [24]. The suspensions
with beads were transferred to a disposable 2 mL polypropylene
column with a frit. The beads were washed with 50 mL of buffer
C, followed by 50 mL of buffer D. Rhodopsin was eluted with
buffer E. The opsin expression and the purity of the purified
rhodopsin were analyzed by SDS-PAGE and the expressed
proteins were electrotransferred onto polyvinylidene fluoride
Figure 2. Analysis of UV-vis spectra of cysteine mutants E113C/
WT, E113/Basal mutant, and G114C/WT. Mutants were purified
from COS-1 cells after regeneration with 25 mM 11-cis-retinal. UV-vis
spectra were recorded in the dark, after acidification, and after
illuminating the samples for 30 sec at 20uC.
doi:10.1371/journal.pone.0017398.g002
Table 1. Characterization of single cysteine substitution
mutants P107C-R135C on the background of the basal mutant
(C140A/167A/185A/222A264A/316A).
Mutants
Chromophore
lmax (nm) A280/A500
*
Meta II decay
(t1/2, min)
WT 500 1.6 14.7
Basal mutant 495 1.7 41
P107C - - -
T108C 495 1.9 16.3
G109C 495 2.4 16
N111C - - -
L112C 495 1.8 15
E113C 380 2.0
# -
G114C - - -
F115C 493 2.0 13
F116C 497 1.7 16
A117C 486 1.8 34
T118C 480 2.0 16.4
L119C 497 1.9 44.5
G120C 494 1.9 40
G121C 485 1.8 1.8
E122C 490 1.75 38
I123C 495 1.9 27
A124C - - -
L125C - - -
W126C - - -
S127C 496 1.8 46
L128C - - -
V129C 496 1.7 42
V130C 496 1.7 35
L131C 495 1.7 37
A132C 494 1.7 20
I133C 495 1.8 29
E134C - - -
R135C 492 2.5 42
R135C 492 2.5 42
*The UV/Vis absorbance spectral ratios were determined after elution from the
immunoaffinity cloumn at pH 6.0.
- The purified mutants P107C, N111C, G114C, A124C, L125C, W126C, L128C, and
E134C did not form rhodopsin-like chromophore.
#the ratio of rhodopsin mutant E113C was 280:380.
doi:10.1371/journal.pone.0017398.t001
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antibody using western blot analysis.
Spectral analysis of WT and the mutant rhodopsins
The formation of the samples’ chromophore was checked by the
difference of UV-visible (UV/vis) absorption spectra before the
rhodopsin was incubated with 1D4-antibody during the protein
purification. UV-visible (UV-vis) absorption spectra of the purified
proteins was recorded with a Perkin-Elmer l-35 UV-vis
spectrophotometer equipped with water-jacketed cuvette holders
connected to a circulating water bath. All spectra were recorded
with a bandwidth of 2 nm, a response time of 1 s, and a scan speed
of 480 nm/min at 20uC either in the dark, after acidification, or
after illuminating the samples for 30 sec with a fiber optic light
equipped with a .495 nm long-pass filter. The molar extinction
value (e500) used for WT rhodopsin was 40,600 M
21cm
21 [22].
The rate of Meta II decay was measured by the fluorescence
increase reflecting the retinal release [27]. Rhodopsin was pre-
equilibrated in 200 mL of 2 mM Na-Pi (pH 6.0) and 0.05% DM at
20uC for 10 minutes, and its fluorescence increase was recorded
after photobleaching for 30 sec. The excitation and emission
wavelengths were 295 nm (slit=0.25 nm) and 330 nm (slit=
12 nm), respectively.
Reaction of rhodopsin-cysteine-mutants/Basal mutant
with sulfhydryl specific reagent 4-PDS
The reaction of rhodopsin cysteine mutants with reagent 4-PDS
is shown in Figure S1 [16]. Rhodopsin mutant samples and buffer
F were mixed with 1 mM 4-PDS such that the final solution
contained 0.5 mM rhodopsin and 25 mM 4-PDS. The reaction at
20uC was then followed by monitoring the absorption of the
product 4-thiophridone at 323 nm in the dark and after
illumination for 30 sec with the same concentration of 4-PDS in
the reference cuvette. Each reaction was followed until comple-
tion, as indicated by no further increase of the absorption at
323 nm. The absorption of the rhodopsin alone at this wavelength
was subtracted. The molar extinction coefficient of 4-thiopyridone
at 323 nm was determined to be 19,000 M
21cm
21 by titration of
L-cysteine with 4-PDS under the same conditions [23]. Due to the
large excess of 4-PDS, the reaction is pseudo-first-order in
sulfhydryl concentration. Therefore, for each reactive mutant,
the increase in 4-thiopyridone as a function of time was fitted by a
single-exponential function to determine the reaction rate
constant. All experiments were independently performed at least
in duplicate. The error given of the pseudo-first-order rate
constant is the standard deviation.
Vacuum electrostatics of Rhodopsin surface charge
analysis
The 3-dimensional structure model and vacuum electrostatics
analyses of rhodopsin were performed with Pymol and the
structure of inactive and partially active rhodopsin [2,7,8].
Results
Spectral characterization of the cysteine mutants P107C-
R135C/Basal mutant or WT
As shown in Table 1, most of the purified-mutants/Basal mutant
except for P107C/, N111C/, G114C/, A124C/, L125C/,
W126C/, L128C/, and E134C/Basal mutant formed the typical
rhodopsin-like chromophore withA280/A500 ratios between 1.7 and
2.5, with an absorption lmax in the visible range varying from
480 nm to 496 nm. The A280/A500 ratio of mutants G109C/Basal
mutant and R135C/Basal mutant was slightly higher, about 2.5.
For mutant E113C/Basal mutant, the lmax of its chromophore was
380 nm. Upon illumination, all mutants except for P107C/,
N111C/, G114C/, A124C/, L125C/, W126C/, L128C/, and
E134C/Basal mutant formed the characteristic Meta II interme-
diates. However, the bleaching behavior was incomplete after
illuminating the samples for 30 sec, in contrast to the basal mutant.
After acidification, most of the bleached samples formed the
440 nm absorbing protonated retinyl Schiff base, but the absorp-
tion lmax of E113 C/Basal mutant and G121C/Basal mutant was
changed to 390 nm (Figure 2 and 3). The purified rhodopsins were
homogeneous as judged by 10% SDS-PAGE (Figure S2).
To examine whether the introduction of cysteine into the TM
helix III affects Meta II decay of rhodopsin, the rate of retinal
release that parallels the Meta II decay of the protein was analyzed
by fluorescence spectroscopy. The rates of Meta II decay (t1/2)
after illumination are shown in Table 1. For WT rhodopsin, the
Figure 3. Analysis of UV-vis spectra of cysteine mutants G121C/WT and G121C/Basal mutant. Mutants were purified from COS-1 cells
after regeneration with 25 mM 11-cis-retinal. UV-vis spectra were recorded in the dark, after acidification, and after illuminating the samples for 30 sec
at 20uC.
doi:10.1371/journal.pone.0017398.g003
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PLoS ONE | www.plosone.org 5 February 2011 | Volume 6 | Issue 2 | e17398t1/2 was 14.7 min under the assay conditions (Figure S3), and the
t1/2 for the cysteine mutants T108C/, G109C/, L112C/, F115C/,
F116C/, and T118C/Basal mutant were similar to WT. The basal
mutant showed significant increases in Meta II half-life (Figure S3),
while the t1/2 for mutants A117C/, L119C/, G120C/, E122C/,
S127C/, V129C/, V130C/, L131C/, and R135C/Basal mutant
varied from 34 to 46 min, which is similar to that of the basal
mutant (t1/2, 41 min) (Table 1). The Meta II half-life of rhodopsin
mutants I123C/, A132C/, and I133C/Basal mutant were between
WT and the basal mutant. The single-cysteine mutant G121C/
Basal mutant (t1/2, 1.8 min) showed the fastest Meta II decay
among rhodopsin mutants (Table 1).
The purified rhodopsin mutants P107C/, N111C/, G114C/,
A124C/, L125C/, W126C/, L128C/, and E134C/Basal mutant
did not form the rhodopsin-like chromophore. Immunoblotting
analysis of the solubilized extracts of cells expressing each mutant
showed that most of the mutants showed a similar level of opsin
expression comparedwith thatofthebasalmutant (datanotshown).
The difference in UV-vis spectra confirmed that there was not the
formation of chromophore in these cysteine mutants (Figure S4).
Each of the single-cysteine mutants on the background of WT
formed the typical rhodopsin-like chromophore except for
G109C/WT; the formation of rhodopsin chromophore of
single-cysteine-mutants/WT is representative (Figure 4). Upon
illumination, all mutants/WT formed the characteristic Meta II
intermediates. The rate of bleaching for all the mutants/WT was
similar to WT except for the mutants A117C/WT and W126C/
WT. Mutants A117C/WT and W126/WT formed the complex
of Meta I and Meta II after illuminating the samples for 30 sec
(Figure 5). Mutant E113C/WT regenerated with 11-cis-retinal
and formed a pigment with lmax=380 nm with a small second
component absorbing at 505 nm. But mutant G114C/WT only
formed a pigment with lmax=380 (Figure 2). Upon illumination,
the pigment was completely converted to the 380 nm form.
Although single-cysteine mutant G121/WT formed the rhodop-
sin-like chromophore, the A280/A500 ratio was significantly
higher at 6.4. Compared with cysteine mutant G121C/Basal
mutant, the replacement of six natural cysteine residues by
alanine led to an increase of A280/A500 ratios from 1.8 to 6.4
(Figure 3).
Reactivity of the Cysteine sulfhydryl groups in mutants
T108C-R135C/Basal mutant to 4-PDS
WT rhodopsin showed 2 mol of reactive cysteines per mole of
rhodopsin (Cys140 and Cys316) in the dark [28]. The basal
mutant (C140A/167A/185A/222A/264A/316A) incorporated
,0.5 mole of the reagent per mole of rhodopsin in the dark or
after illumination for 30 sec. The cysteine mutants L112C-
A132C/Basal mutant incorporated approximately 0.5 mole of
the reagent per mole of rhodopsin in the dark, which was similar
to that of the basal mutant. The reaction was completed within
several minutes, as little increase was detected upon further
incubation. However, for mutants T108C/Basal mutant and
G109C/Basal mutant, both incorporated ,1.0 mole of 4-PDS per
mole of rhodopsin, and mutants I133C/Basal mutant and
R135C/Basal mutant incorporated ,1.5 mole of the reagent
per mole of rhodopsin in the dark.
Upon photoactivation, these mutants incorporated ,1 mole of
the reagent per mole of rhodopsin over time after illuminating the
samples for 30 sec. After light activation, comparison of the rate of
reactivity calculated from absorbance increase at 323 nm
indicated that mutants T108C/, G109C/, E113C/, and
L131C/Basal mutant showed rapid reactions with 4-PDS.
Reaction rate of mutants L112C/, G121C/, and A132C/Basal
mutant with 4-PDS was moderate, while mutants F115C/,
T118C/, L119C/, V129C/, V130C/, and R135C/Basal mutant
showed a slow rate of reaction with 4-PDS. The slower reactions
were observed with F116C/, A117C/, G120C/, E122C/, I123C/,
S127C/, and I133C/Basal mutant. The cysteine mutant E113C/
Basal mutant showed the fastest reaction rate with 4-PDS among all
of the mutants at helix-III. The time courses for the reactions and
exponential fits for selected mutants are shown in Figure 6A and
Figure S5, and the pseudo-first-order rate constants for all of the
mutants are listed in Table 2 and Figure 6B.
The big group including L112C-A132C/Basal mutant showed
no reaction at all using prolonged times, but G109C/Basal and
Figure 5. Analysis of UV-vis spectra of single-cysteine mutants A117C/WT and W126C/WT. Mutants were purified from COS-1 cells after
regeneration with 25 mM 11-cis-retinal. UV-vis spectra were recorded in the dark, after acidification, and after illuminating the samples for 30 sec at
20uC.
doi:10.1371/journal.pone.0017398.g005
Figure 4. Analysis of UV-vis spectra of some selected single-cysteine mutants of rhodopsin on the background of wild-type
rhodopsin. Mutants (Basal mutant, P107C/, N111C/, E122C/, A124C/, L125C/, and L128C/WT) were purified from COS-1 cells after regeneration with
25 mM 11-cis-retinal. UV-vis spectra were recorded in the dark, after acidification, and after illuminating the samples for 30 sec at 20uC.
doi:10.1371/journal.pone.0017398.g004
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that hydrophobic/hydrophilic phase boundaries exist at positions
of G109 and I133 of Helix-III. To determine whether the
cysteine accessibility data agree with the accepted rhodopsin 3-
dimensional structural model, two mutants GI09C/Basal mutant
and I133C/Basal mutant were analyzed by vacuum electrostatics
of rhodopsin surface charge changes in the inactive and partially
active states (Figure 7 and Figure 8). The analysis data clearly
Figure 6. Comparison of PDS labeling rate among cysteine mutants and relationship analysis of PDS labeling rate with Meta II
decay. A) Rates of cysteine reactivity with 4-PDS were evaluated in mutants (F115/, F116/, A117/, T118/, V130/, L131/, A132/, I133/, and R135/Basal
mutant). The reaction was carried out with 0.5 mM of rhodopsin mutant and 25 mM 4-PDS in phosphate buffer (pH8.0) and 0.05% DM at 20uC. Time-
dependent changes in absorbance at 323 nm after photoactivation were plotted. B) Rates of cysteine reactivity with 4-PDS (dark gray) and Meta II
decay (light gray) in relationship to the amino acid position.
doi:10.1371/journal.pone.0017398.g006
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exist at positions of G109 and I133, which is consistent with the
above-mentioned results. Furthermore, compared to the position
changes at G109 and I133 between inactive and partially active
structure, the helix-III showed little to no movement (Figure 7
and Figure 8).
Discussion
The crystal structure of rhodopsin in the ground state provided
the first detailed three-dimensional structural model for a GPCR
[2,29]. So far, only the crystal structure of partially activated
rhodopsin has been resolved [7,8]. Due to difficulties of getting the
crystal structure of completely activated rhodopsin, several
biochemical approaches have been employed to analyze its
structural changes upon activation. In particular, cysteine
scanning mutagenesis followed by analysis of reactivity of cysteine
sulfhydryl groups has been extremely useful for delineating
structural features of rhodopsin. The accessibility and reactivity
measurement of single cysteines, introduced into various positions
of the molecule, provides useful clues not only for the secondary
and tertiary structural features of rhodopsin in the dark and upon
photoactivation but also for the aqueous/TM boundary of the
protein molecule.
Light-catalyzed retinal isomerization causes specific movements
in the TM helices, resulting in a conformational change in the CP
domain preparing the molecule for the protein-protein interac-
tions involved in signal transduction [30,31]. Rhodopsin is
composed of a seven-TM helical protein domain (Figure 1). TM
Helix-III is of significance from several points of view: 1) The
larger conformational changes occur at the interhelical loops near
the ends of the TM helices III and VI [31], which contribute to the
binding site of the C-terminus of transducin a; 2) Helix-III
provides many of the amino acid side chains that form the
chromophore-binding pocket: E113, G114, A117, T118, G120,
and G122 [32], and G121 is an important and specific component
of the 11-cis-retinal binding pocket in rhodopsin [33,34]; E113
serves as 11-cis-retinal Schiff base counterion [35]; 3) Cys-110 and
Cys-187 form a disulfide bond to stabilize the rhodopsin structure;
4) The tripeptide E134-R135-Y136 is part of a highly conserved
(D/E)R(Y/W) motif found in GPCRs, which participates in
several hydrogen bonds with surrounding residues [2,7,8]. Proton
uptake involves the ERY motif near the cytoplasmic surface of TM
Helix-III during formation of Meta II [11,36]. The rhodopsin
activation in membranes is regulated by two protonation switches,
including disruption of an interhelical salt bridge by internal
proton transfer from the retinal protonated Schiff base to its
counterion E134, and uptake of a proton from the solvent by E134
[10]. The conserved NpxxY(x)5,6F (D/E)R(Y/W) motif provides
structural constraints in rhodopsin that rearrange in response to
photoisomerization during formation of the G protein-activating
Meta II [37].
As shown in Figure 4, the basal mutant regenerated with 11-cis-
retinal similarly to the WT, with an A280/A500 ratio of 1.7 and an
absorption visible maximum slightly blue-shifted to 495 nm. Thus,
11-cis-retinal binding to the basal mutant is near normal, the
structure of the basal mutant is similar to that of WT rhodopsin
and the substituted alanines lie in a similar orientation to that of
the WT cysteine residues [38]. However, the basal mutant
markedly differed from WT in Meta II half-life showing significant
increase (,41 min) (Figure S3). Namely, the rate of retinal release
of the basal mutant is slower than that of WT. The alanine-
substitution mutant prolonged the Meta II decay, which from an
experimental point of view is very convenient to determine
reactivity of the cysteine sulfhydryl groups in single-cysteine
mutants on the background of the basal mutant to 4-PDS after
photoactivation.
Two of the studied mutants, G109C/Basal mutant and R135C/
Basal mutant, regenerated with 11-cis-retinal to different levels
when compared to the WT (Table 1). The A280/A500 ratio was
significantly increased to ,2.5, indicating some degree of
misfolding for these two mutants. This concurs with the previously
reported spectrum of R135L [39] and is different from other
reported mutations at amino acid position R135, such as R135G,
R135T [40], or R135Q [35], respectively. This differential effect
suggests that the size chain at position 135 may play a crucial role
in rhodopsin folding. In addition, R135 formed a salt-bridge with
E134 and E247 at the top of TM helices III and VI, holding these
two helices together at their cytoplasmic ends and maintaining the
receptor in its inactive state [2,39]. Thus, the R135C/Basal
mutant mutation would be disrupting this ionic interaction,
resulting in partially misfolding and a reduced ability of the
mutant protein to bind 11-cis-retinal. In the case of mutant
G109C/Basal mutant, the inserted amino acid is close to a
conserved disulfide bond (Cys110–Cys187) in rhodopsin. The
higher A280/A500 ratio indicates that a cysteine substitution at
position 109 may affect the correction matching of the disulfide
bond. In the control experiment, G109C/WT did not form the
rhodopsin-like chromophore, but G109C/Basal mutant formed
the chromophore. This result suggests that the amino acid cysteine
at position 109 may form an erroneous disulfide bond with
Table 2. Comparison of the reactivity of cysteine mutant T108C-R135C/Basal mutant at Helix-III of rhodopsin with 4-PDS after
photoactivation.
mutant Rate (min
21)
a mutant Rate (min
21)
a mutant Rate (min
21)
a
T108C .1.4
b T118C 0.05460.006 V129C 0.05760.006
G109C .1.4
b L119C 0.07460.008 V130C 0.05360.011
L112C 0.24260.0537 G120C 0.03260.005 L131C .1.4
b
E113C .1.4
b G121C 0.30260.06 A132C 0.17760.035
F115C 0.08860.011 E122C 0.03660.006 I133C 0.02160.003
F116C 0.04760.008 I123C 0.04860.007 R135C 0.10360.013
A117C 0.04860.007 S127C 0.04260.006 Basal mutant 0.04160.005
aThe error given of each value of the pseudo-first-order rate constant is the standard deviation.
bThese reactions were complete at the first time point taken (,0.5 min).
doi:10.1371/journal.pone.0017398.t002
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of the protein.
The rate of Meta II decay of mutant G121C/Basal mutant
(1.8 min) was the fastest among the cysteine mutants (Table 1).
Acidification resulted in reprotonation of the Schiff base linkage at
the visible band shifted to 390 nm. In addition, compared with
single-cysteine mutant G121C/WT, we note that the G121C/
Basal mutant led to an increase of A280/A500 ratios from 1.8 to 6.4
(Figure 3). G121 is close to F261 (helix-VI) in the rhodopsin crystal
structure; they pair to form one boundary of the retinal-binding
site, defining the C4-C5-C18 orientation (F261 Cz-G121Ca
distance, 5 A ˚; F261 Cz-retinal C4 distance, 3.7 A ˚) [2]. This
portion of the retinal-binding pocket around helices III and VI
appears to be held rigidly together by tight van der Waals
interactions [32]. The interaction between G121 and retinal is
consistent with mutagenesis experiments in which replacement
of G121 by cysteine caused blue-shifted lmax values
(500 nmR485 nm) and decreased retinal binding that corre-
sponded to the bulk of the substituted side chain. G121 also is a
specific component of the 11-cis-retinal binding pocket in
rhodopsin [33]. These data can explain why the mutant
G121C/Basal mutant contains a faster rate of Meta II decay
and why it is different from UV-vis spectrum. Evidence also
showed that second-site replacement of F261 by alanine caused a
reversion of the loss-of-function G121 mutant phenotypes, which
is consistent with the interpretation that G121 and F261 may
interact to form part of the retinal-binding pocket [34]. The six
natural cysteine (C140RC-II, C167RHelix III, C185RE-II,
C222RHelix V, C264RHelix VI, and C316RHelix VIII)
replacements by alanine resulted in a recovery of the loss of
function of single-cysteine mutant G121C/WT (Figure 3). Further
studies will be performed to clarify which cysteine is the key amino
acid to recover the function of this mutant.
In the current report, the substitution of E113 by cysteine
(E113C/WT) also formed a markedly blue-shifted pigment
(lmax=380 nm) and a slightly red-shifted pigment (lmax=
505 nm) (Figure 2). The pigment (lmax=505 nm) of the mutant
E113C/Basal mutant completely converted to lmax=380 nm
(Figure 2). This is similar to mutant E113Q forming two pigments
that were composed of lmax=380 nm and lmax=490 nm. The
380-nm species of mutant E113Q existed in a pH-dependent
equilibrium with a 490-nm species such that at acidic pH all of the
pigment was converted to lmax=490 nm. However, for mutant
E113C/WT subsequent acidification resulted in reprotonation of
the Schiff base linkage as the visible band shifted back to 440 nm
(Figure 2). Mutant E113C/Basal mutant only formed a pigment
(lmax=380 nm). After acidification, the chromophore changed to
390 nm (Figure 2). The E113 is unprotonated and negatively
charged in the ground state of rhodopsin [41]. However, E113
becomes protonated upon light-dependent formation of Meta II
and is the net proton acceptor for the Schiff base proton [42]. The
pI of the amino acids cysteine and glutamine is 5.15 and 5.65,
respectively, higher than that of glutamic acid (pI=3.08). Thus,
the substitution of glutamic acid-113 by glutamine and cysteine
showed similar UV-vis spectra, but having a different spectra
characterization as compared with WT.
The mutant G114C/WT formed similar UV-vis spectra to
E113C/Basal mutant, showing a pigment in light absorption
(lmax=380 nm) (Figure 2). The amount of protein recovered from
the immunoaffinity column is very low when compared with that
of WT. The lower A280/A500 ratio indicates the misfolding of
G114C/WT. In addition, the mutants at position 114 have been
shown not to regenerate with 11-cis-retinal [33,39]. Because G114
is a key amino acid to form retinal binding pocket, the substitution
of glycine-114 by cysteine reduced the binding ability of rhodopsin
to 11-cis-retinal.
Mutants A117C/WT and W126C/WT formed the complex of
Meta I and Meta II after illuminating the samples for 30 sec
(Figure 5). The chromophore of W126C/WT red-shifted to
lmax=484 nm. Increasing illumination time resulted in more
Meta II formation. UV-absorption spectroscopy has suggested that
the local protein environment around Trp residues changes during
the conversion of rhodopsin to Meta II, and a linear dichroism
study of UV-difference bands indicated a reorientation of an
indole side chain of Trp during the Meta I to Meta II conversion
[32].
Mutants P107C, N111C, G114C, A124C, L125C, W126C,
L128C, and E134C on the background of the basal mutant failed
to regenerate with 11-cis-retinal. The absence of chromophore
regeneration for these mutants was confirmed by western blotting
and UV-vis absorption spectra (Figure S4). However, the above-
mentioned single cysteine mutants/WT can form the chromo-
phore (Figure 4).
A number of factors could affect the reactivity of the sulfhydryl
groups in different cysteines, including solvent accessibility,
disposition within the structure, and the dielectric constant
prevailing in the immediate environment [23]. In the dark, one
big group, which showed no reaction at all using prolonged times,
is composed of L112C-A132C/Basal mutant except for E113C/
Basal mutant. Lack of reactivity of a sulfhydryl group in a cysteine
indicates that the residue is buried either in a tertiary structure or
in the hydrophobic micelle interior. According to our accessibility
data, an aqueous/hydrophobic boundary in helix-III is near G109
and I133. Vacuum electrostatics analysis of rhodopsin surface
charge clearly showed that hydrophobic/hydrophilic phase
boundaries exist at positions of G109 and I133 (Figure 7 and
Figure 8). Furthermore, the second proton at E134 during
formation of Meta II has been shown to be functional in the
isolated synthetic Helix-III and operates specifically at the phase
boundary [11], which is of direct relevance to the placement of the
phase boundary at I133 in cysteine accessibility data.
Another group, which showed markedly different reaction rates
with 4-PDS, includes T108C/, G109C/, E113C/, and L131C/
Basal mutant. The high accessibility of cysteine in mutant E113C/
Basal mutant with 4-PDS in the dark demonstrated that the
internal salt bridge with the Schiff base was broken by a cysteine
Figure 7. Vacuum electrostatics analysis of rhodopsin surface charge shows that hydrophobic/hydrophilic phase boundaries exist
at position G109 of the intercellular domain. A) Left: cartoon and stick model of rhodopsin (inactive) with the basal mutants in gray and G109C
in purple. Black lines show the hydrophobic/hydrophilic phase boundaries. Number 1–7 show the transmembrane helices. Right: vacuum
electrostatics model of rhodopsin (inactive) shows the highly charged hydrophilic phase (negative in red and positive in blue) both in the cytoplasmic
and intracellular areas and the low/non charged hydrophobic phase (between the yellow lines) in the membrane bilayer area. Purple-blue dots show
the location of G109. B) Left: the cartoon and stick model of rhodopsin (partially active) with the basal mutants in gray and G109C in purple. Black
lines show the hydrophobic/hydrophilic phase boundaries. Number 1–7 show the transmembrane helices. Right: vacuum electrostatics model of
rhodopsin (partially active) shows the highly charged hydrophilic phase (negative in red and positive in blue) both in cytoplasmic and intracellular
areas and the low/non charged hydrophobic phase (between the yellow lines) in the membrane bilayer area. Purple-blue dots show the location of
G109. Bar (bottom) shows the negative and positive charge.
doi:10.1371/journal.pone.0017398.g007
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the dark. The rates of reaction with 4-PDS upon illumination are
shown in Table 2 for all of the cysteine mutants, and kinetic plots
for selected mutants are showed in Figure 6A and supplementary
Figure 5. Wide variation in reactivity was observed among cysteine
mutants at different positions in the sequence 108–135 after
photoactivation. Mutants E113C/, T108C/, G109C/, and
L131C/Basal mutant reacted so rapidly that their reactions were
complete at the first time point taken (,0.5 min). A second group,
comprising L112C/, G121C/, and A132C/Basal mutant, showed
variations, but the rates were intermediate. Cysteines at positions
116, 117, 120, 122, 123, 127, and 133 reacted extremely slowly
with 4-PDS, and mutants F115C/, T118C/, L119C/, V129C/,
V130C/, and R135C/Basal mutant reacted with 4-PDS faster
than those of F116C/Basal mutant. For mutants L112C-A132C/
Basal mutant, excepting E113C/Basal mutant, the lack of
reactivity in the dark and the accessibility of cysteine after
photoactivation indicate the increases of water/4-PDS accessibility
for certain cys-mutants. Comparing the position changes at G109
and I133 between inactive and partially active structure by
vacuum electrostatics analysis of rhodopsin surface charge, the
helix-III showed little movement (Figure 7 and Figure 8), which is
consistent with a pattern of helix switch due to activation [9,13];
namely, the activated rhodopsin has an outward movement of
TM-VI, and smaller movements involving TM-I, TM-V, TM-
VII, and TM-VIII, while the other helices remain largely
unchanged.
The relationship between the mutant Meta II decay and the
cysteine accessibility in these mutants/Basal was also addressed
(Figure 6B). The mutant Meta II decay was mainly dependent on
their location at Helix-III. Most of the mutants affecting amino
acids close to TM N-terminus, including T108C, G109C, L112C,
F115C, F116C, and T118C/Basal mutant showed a short Meta II
decay (t1/2,16 min), which is similar to that of WT (t1/2,
14.7 min), whereas most of mutants involving amino acids near
the TM C-terminus, including L119C-R135C/Basal mutant,
showed a long Meta II decay (t1/2,40 min), which is similar to
that of basal mutant (t1/2, 41 min) (Table 1 and Figure 6B).
However, according to the accessibility data of the buried residues
in the membrane bilayer, most of mutants showed a slow reaction
rate with 4-PDS within membrane bilayer (Figure 6B and Table 2).
Thus, it does not seem to exist a relationship between the Meta II
decay of the mutants and the cysteine accessibility.
Water reorganization following photoactivation releases the
constraints mediated by ionic lock (ERY motif), and a secondary
internal hydrogen bonding network (Y206-H211-M163-E122),
which may imply movement of water molecules and/or side
chains and structural alterations of the helices [12]. The
distribution and functional plasticity of water molecules in the
TM region contribute to the absence of large conformational
changes in rhodopsin after photoactivation [13,14]. Photoactiva-
tion disrupts and reorganizes multiple constrains mediated by side
chains and bound water, which transmits signaling from the
chromophore and opens a groove on the cytoplasmic surface of
the receptor, finally promoting catalytic exchange of GDP to GTP
in transducin a. An increase of water/4-PDS accessibility for
certain cys-mutants at Helix-III during formation of Meta II
indicates an opening along the region of binding 11-cis-retinal.
According to Altenbach’s and Grossfield’s recently published
studies [9,14], it is possible to predict that the minimal ‘‘opening’’
of the heptahelical structure for 4-PDS accessibility on water
uptake is approximately 3–5 A ˚ after light activation.
In summary, our data show that an aqueous/hydrophobic
boundary in helix-III is near G109 and I133. The chromophore-
facing residues of Helix-III become water-accessible after
photoactivation.
Supporting Information
Figure S1 Schematic representation of the rhodopsin cysteine
mutants with 4-PDS. The reaction product thiopyridone is
maximum at 323 nm. Thus, the reaction kinetics and the number
of reactive cysteines can be determined by monitoring the
absorption at this wavelength.
(TIF)
Figure S2 10% SDS-PAGE analysis of the purified cysteine
mutants on the background of basal mutant.
(TIF)
Figure S3 Meta II decay of wild type rhodopsin and basal
mutant. The changes in fluorescence were measured in a buffer
containing 2 mM Na-Pi (pH 6.0) and 0.05% DM after illuminat-
ing the samples for 30 sec at 20uC.
(TIF)
Figure S4 UV-Vis spectra of rhodopsin cysteine mutant
L125C/Basal mutant and E134C/Basal mutant. Mutants were
purified from COS cells after regeneration with 25 mM 11-cis-
retinal. UV-Vis spectra were recorded in the dark with rhodopsin
eluted in a buffer containing 2 mM NaPi (pH6.0), 0.05%DM,
100 mM C’ 1–9 peptide and 100 mM NaCl.
(TIF)
Figure S5 Comparison of PDS labeling rate among cysteine
mutants. These mutants include T108/, G109/, L112/, E113/,
L119/, G120/, G121/, E122/, and I123/Basal mutant. The
reaction was carried out with 0.5 mM of rhodopsin mutant and
25 mM 4-PDS in phosphate buffer (pH8.0) and 0.05% DM at
20uC. Time-dependent changes in absorbance at 323 nm after
photoactivation were plotted.
(TIF)
Figure 8. Vacuum electrostatics analysis of rhodopsin surface charge shows that hydrophobic/hydrophilic phase boundaries exist
at positions of I133 at cytoplasm side. A) Left: the cartoon and stick model of rhodopsin (inactive) with the basal mutants in gray and I133C in
brown. Black lines show the hydrophobic/hydrophilic phase boundaries. Number 1–7 show the transmembrane helices. Right: vacuum electrostatics
model of rhodopsin (inactive) shows the highly charged hydrophilic phase (negative in red and positive in blue) both in cytoplasmic and intracellular
areas and the low/non charged hydrophobic phase (between the yellow lines) in the membrane bilayer area. Purple-blue dots show the location of
I133. B) Left: the cartoon and stick model of rhodopsin (partially active) with the basal mutants in gray and I133C in brown. Black lines show the
hydrophobic/hydrophilic phase boundaries. Number 1–7 show the transmembrane helices. Right: vacuum electrostatics model of rhodopsin (partially
active) shows the highly charged hydrophilic phase (negative in red and positive in blue) both in cytoplasmic and intracellular areas and the low/non
charged hydrophobic phase (between the yellow lines) in the membrane bilayer area. Purple-blue dots show the location of I133. Bar (bottom) shows
the negative and positive charge.
doi:10.1371/journal.pone.0017398.g008
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